MIRA INFORM REPORT

 

 

 

Report Date :

20.09.2008

 

IDENTIFICATION DETAILS

 

Name :

RANTUS PHARMA PRIVATE LIMITED

 

 

Registered Office :

401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

07.02.2003

 

 

Com. Reg. No.:

40459

 

 

CIN No.:

[Company Identification No.]

U24239AP2003PTC040459

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDR02310A

 

 

PAN No.:

[Permanent Account No.]

AACCR3767N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals Ingredients.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 122000

 

 

Status :

Good

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having satisfactory track. Directors are reported as experienced, respectable and resourceful businessmen. Their trade relations are fair. Payments are usually correct and as per commitments.

 

The concern can be considered good for normal business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Krishna Reddy

Designation :

Account Department

Date :

06.09.2008

 

 

LOCATIONS

 

Registered Office :

401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

E-Mail :

info@rantuspharma.com

Website :

www.rantuspharma.com

Area :

1000 sq ft

Location :

Owned

 

 

Factory :

Flat No. 215, Bhanu Enclave, Erragadda, Hyderabad – 500038, Andhra Pradesh, India

Tel. No.:

91-40-23818293

91-40-23706123 (Marketing Department)

Fax No.:

91-40-23810649

E-Mail :

info@rantuspharma.com

Area :

900 sq ft

Location :

Rented

 

 

Factory 2 :

Plot No.29/ DA Phase 2, Pasany Loram  39, Patahcheru, Andhra Pradesh

Tel No.:

91-8455-225515

Area :

2 Acers

Location :

Owned

 

 

DIRECTORS

 

Name :

Mr. K Umamaheswara Rao

Designation :

Managing Director

Address :

Flat No.410, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

Date of Birth/Age :

30.07.1962

Qualification :

BSC

Date of Appointment :

17.06.2003

 

 

Name :

Mr. K Ratnakumari

Designation :

Director

Address :

Flat No.410, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

Date of Birth/Age :

13.06.1967

Qualification :

B.Com

Date of Appointment :

17.02.2003

 

 

Name :

Mr. N Soudhamani

Designation :

Director

Address :

24- 110, Kakathiya nagar, road no.3, Ashok Nagar, Hyderabad – 500032, Andhra Pradesh

Date of Birth/Age :

13.06.1967

Qualification :

B.Com

Date of Appointment :

17.02.2003

 

 

Name :

Mr. Udadagiri Tata Rao

Designation :

Director

Address :

F. No.501, Sree Maruthi Heights, Sanjeeva Reddy Nagar, Hyderabad- 500038, Andhra Pradesh

Date of Birth/Age :

13.06.1960

Date of Appointment :

07.02.2003

 

 

Name :

Mr. Sundera Pullaiah Naidu

Designation :

Director

Address :

F. no.101, rukmini Enclave, Dharamkaram Road, Ameerpet, Hydearbad – 500038, Andhra Pradesh.

Date of Birth/Age :

1.01.1960

Date of Appointment :

07.02.2003

 

 

KEY EXECUTIVES

 

Name :

Ravi and Subramanyam

Designation :

Company Secretary

Address :

H. No. 5-9-71/22/B, MCH No.250, Opposite to Darpan Boutique Adarsh Nagar, Near Birla Mandir, Hyderabad – 500063

Phone No.:

91-40-23242325/ 23242326

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.09.2007

 

Names of Shareholders

 

No. of Shares

Mr. K Umamaheswara Rao

 

208815

Mr. K Ratnakumari

 

362685

Mr. N Soudhamani

 

178500

Total

 

750000

 

AS ON 29.09.2007

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Ingredients.

 

 

Product :

·       APIs

·       Intermediates

 

 

Exports :

 

Products :

Pharmaceuticals Products

Countries :

Hong Kong, Pakistan

 

 

Imports :

 

Countries :

China

 

 

Terms :

 

Selling :

L/C and T/T

 

 

Purchasing :

L/C and T/T

 

 

GENERAL INFORMATION

 

No. of Employees :

75 (office – 15, Factory - 60)

 

 

Bankers :

UCO Bank, Banjara Hill Branch

 

 

Facilities :

CC Limit Rs.15.000 Millions and L/C Rs.15.000 Millions

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Ramanatham and Company

Mr. C Kameswara Rao

Chartered Accountant

Membership No.:

24363

Address :

302, Kalamansion, S D Road, P B No. 2102, Secunderabad 500003

Tel. No.:

91-40-27814147

Fax No.:

91-40-27840307

 

 

Sister Consist :

Alekha Durga Private Limited

Address :

Andhra Pradesh

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2007

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs. 10/- Each

Rs.10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

750000

Equity Shares

Rs. 10/- Each

Rs.7.500 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

Particulars

 

 

 

31.03.2008

Sales Turnover

 

 

220.000

 

Expected Sales (2008-09) : Rs.300.000 Millions

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

7.500

0.100

0.100

2] Share Application Money

0.918

8.248

7.400

3] Reserves & Surplus

15.982

5.640

1.182

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

24.400

13.988

8.682

LOAN FUNDS

 

 

 

1] Secured Loans

17.978

13.407

9.252

2] Unsecured Loans

18.680

22.335

5.413

TOTAL BORROWING

36.658

35.742

14.665

DEFERRED TAX LIABILITIES

1.346

0.818

0.299

 

 

 

 

TOTAL

62.404

50.548

23.647

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

31.405

21.939

16.884

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

5.830

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

23.660

14.107

16.529

 

Sundry Debtors

67.098

57.955

16.801

 

Cash & Bank Balances

6.186

1.301

0.706

 

Other Current Assets

2.520

6.220

4.234

 

Loans & Advances

1.104

3.103

0.353

Total Current Assets

100.568

82.686

38.623

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

74.034

53.180

31.571

 

Provisions

1.732

0.908

0.304

Total Current Liabilities

75.766

54.088

31.875

Net Current Assets

24.802

28.598

6.747

 

 

 

 

MISCELLANEOUS EXPENSES

0.006

0.010

0.015

 

 

 

 

TOTAL

62.404

50.548

23.647

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Sales Turnover

214.785

166.072

58.028

Job Work

7.372

2.859

2.220

Other Income

0.078

0.363

0.005

Total Income

222.235

169.294

60.253

 

 

 

 

Profit/(Loss) Before Tax

13.947

5.976

0.997

Provision for Taxation

2.855

1.519

1.367

Profit/(Loss) After Tax

11.092

4.457

0.729

 

 

 

 

Export Value

10.037

9.493

0.825

 

 

 

 

Expenditures :

 

 

 

 

Administrative Expenses

1.974

1.746

0.735

 

Increase/(Decrease) in Finished Goods

8.143

(0.271)

4.404

 

Depreciation & Amortization

1.408

0.845

0.573

 

Other Expenditure

196.763

160.998

53.544

Total Expenditure

208.288

163.318

59.256

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

04.99

02.63

01.20

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

06.49

03.59

01.71

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

10.12

05.71

01.79

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

57.15

42.72

11.48

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

4.60

6.42

5.36

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.32

1.52

1.21

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade Reference

·       Cipla

·       Cadila

·       Epka

 

 

 

 

 

FORM NO.8

 

This form is for

Creation of charge

Corporate identity number of the company

U24239AP2003PTC040459

Name of the company

RANTUS PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad – 500072, Andhra Pradesh.

Type of charge

Immovable Property

Others

Particular of charge holder

Name :

State Bank of India

Address :

Self Employment Industrial Estate, Kaattedan, Hyderabad – 500077, Andhra Pradesh, India

Email :

Sa.05328@sbi.co.in

Nature of description of the instrument creating or modifying the charge

Corporate Guarantee

Memorandum of deposit of title deed

Date of instrument Creating the charge

29.03.2007

Amount secured by the charge

Rs.70.000 Millions

Short particulars of the property charged

Land admeasuring 5.125 Acers situated at Tangadapally, Choutuppal – Nalgonda District

 

 

Name of the company

RANTUS PHARMA PRIVATE LIMITED

Presented By

K. Umamaheswara Rao Private Limited

1) Date and description of instrument creating the change

·       Hypothecation of goods to secured demand cash credit

·       Hypothecation and book debts to secure demand cash credit

·       Agreement for extension of charge by way of hypothecation over current assets to secured non fund based facilities

All dated 14.02.2005

2) Amount secured by the charge/amount owing on the securities of charge

Rs.10.000 Millions for cash credit

Rs.5.000 Millions for letter of credit

Agreement to Rs.15.000 millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of stocks debtor and other current assets and Plant and Machinery

4) Gist of the terms and conditions and extent and operation of the charge.

Interest rate of 2% p.a. above the deposit rate/ UCO bank prime lending rate which is at present 11% p.a. subject to minimum rate of interest of 13% p.a. or at such other rate as may be denied by UCO Bank from time to time under intimation with monthly rests for value received.

5) Name and Address and description of the person entitled to the charge.

UCO Bank, M.G. Road Branch, Secunderabad

6) Date  and brief description of instrument modifying the charge

NA

 

 

 

 

 

 

 

 

 

WEB DETAILS ATTACHED

 

Values

Commitment to quality in everything they do, innovation and continuous improvement, collaboration and teamwork, harmony and social responsibility. Their business practices are guided by ethics, honesty, and transparency.

Mission

They will endeavour to achieve the highest standards in their Production and Quality to delight their customers.

The Company

Subject manufactures high-quality Active Pharmaceutical Ingredients (APIs) and Intermediates. They have their state-of-the-art manufacturing facilities at IDA Pasamailaram near Hyderabad, Andhra Pradesh, India.

Their primary objective is to achieve highest customer satisfaction by supplying high-quality APIs and Intermediates to meet their requirements.

Their quest has been to sustain and improve the quality of APIs and Intermediates.

The Infrastructure

They have 20 Stainless Steel Reactors and 4 Glass Lined Reactors, and have plans to expand their infrastructure considerably. They have the capacity to produce in excess of 10 Tons of APIs and Intermediates per month.

DISCLAIMER:

  1. These products are not offered to those countries which are conflicting with existing patents.
  2. The final responsibility shall lie with the buyer only.

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.46.32

UK Pound

1

Rs.83.57

Euro

1

Rs.65.90

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

*

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions